The Journal of Allergy and Clinical Immunology: In Practice
Clinical CommunicationsVirus Reactivation in Drug Reaction with Eosinophilia and Systemic Symptoms (Dress) Results from a Strong Drug-Specific Immune Response
Section snippets
Virus Reactivation is an Original Feature of Dress
Many investigators have reported that DRESS was accompanied by reactivation of one or several viruses of the herpes group, including human herpesvirus 6 (HHV6), HHV7, Epstein Barr virus (EBV), and human cytomegalovirus,1, 2 with a peak 2 to 3 weeks after initial symptoms.1 Virus reactivation has been reported in up to 60% of patients with DRESS,2 but it is neither invariable nor specific for DRESS, because viral activation has also been observed, even if less frequently, in other severe
Strong Drug-Specific Immune Response is Another Original Feature of Dress
In the current issue of JACI: In Practice, Hensel et al6 describe the immunopathologic features of a positive patch test to ceftriaxone in a case of DRESS, with a similar pattern to that of a prior biopsy of the rash, and suggesting a mixed type IVb and IVc hypersensitivity. Too few similar reports of patch test biopsies are available in DRESS, and more would be welcome.
If not definitely conclusive on immunological mechanisms of DRESS, the demonstration of positive patch tests to drugs is a
What is the Most Likely Primary Event in DRESS: Virus Activation or Drug Allergy?
There is no credible explanation of how virus reactivation, peaking 2 to 3 weeks after onset of DRESS,1 could induce a drug-specific immune response. Supporters of the viral theory of DRESS often refer both to the high frequency of eruptions due to aminopenicillins observed during EBV primary infection (infectious mononucleosis) and to the high rates of ADRs in persons living with human immunodeficiency virus (HIV). However, the incidence of amoxicillin-induced rash in pediatric patients with
References (17)
- et al.
The drug hypersensitivity syndrome (DRESS syndrome) is nothing but a viral illness
Rev Fr Allergy
(2010) - et al.
Human herpesvirus-6 (HHV-6) DNA in plasma reflects the presence of infected blood cells rather than circulating viral particles
J Clin Virol
(2007) - et al.
Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS
J Am Acad Dermatol
(2002) - et al.
The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome
Allergy
(2014) - et al.
Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome
Br J Dermatol
(2007) - et al.
Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response
Sci Transl Med
(2010) - et al.
Drug reaction with eosinophilia and systemic symptoms from ceftriaxone confirmed by positive patch test: an immunohistochemical study
J Allergy Clin Immunol Pract
(2017) - et al.
A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions
Br J Dermatol
(2013)
Cited by (18)
Does sensitization by SARS-CoV-2 immune complexes trigger DRESS syndrome?
2022, Brazilian Journal of Infectious DiseasesCitation Excerpt :The difficult differential diagnosis, especially with infectious diseases, increases mortality to 5–10% of the patients due to liver failure.14–17 Over 60% of the DRESS syndrome cases are associated with viral infection, especially human herpesvirus 6 and 7, Epstein Barr virus, and human cytomegalovirus.18 Numerous drugs from different categories have been involved in the DRESS syndrome, and its incidence seems to have been aggravated during the current pandemic.
Successful treatment of corticosteroid-dependent drug reaction with eosinophilia and systemic symptoms with cyclosporine
2021, Annals of Allergy, Asthma and ImmunologyCitation Excerpt :Some of the most common medications that causes DRESS include aromatic anticonvulsant, sulfonamides, and allopurinol.2 DRESS is also associated with viral infections or reactivation of herpes viruses, such as human herpesvirus 6, human herpesvirus 7, Epstein-Barr virus, and cytomegalovirus.3,4 Clinically, it presents with extensive morbilliform skin rash, fever, lymphadenopathy, hematological abnormalities (hypereosinophilia, atypical lymphocytes), and multiorgan involvement, including renal, hepatic, pulmonary, cardiac, and endocrine abnormalities.5,6
The Journal of Allergy and Clinical Immunology: In Practice 2017 Year in Review
2018, Journal of Allergy and Clinical Immunology: In PracticeCitation Excerpt :The other case series found HLA B62 in 3 of 6 cases of DRESS due to piperacillin/tazobactam, suggesting that it may be a risk factor for this condition.106 An editorial by Roujeau and Dupin254 discussed the role of virus reactivation in DRESS. Finally regarding SCARS, Trubiano et al255 reported a case of teicoplanin-induced TEN confirmed by in vitro tests (see below).
Intravenous Immunoglobulin May Be Beneficial as an Add-on Therapy in DRESS
2018, Journal of Allergy and Clinical Immunology: In Practice
No funding was received for this work.
Conflicts of interest: J.-C. Roujeau is on a Pfizer safety board; has received consultancy fees from Ab Science, Novartis, Clinicgen, and Menarini; and has provided expert testimony for McNeil consumers. N. Dupin declares no relevant conflicts of interest.